TWO · 4167.TWO
Savior Lifetec Corp.
NT$20.10-NT$0.30 (-1.47%)
Savior Lifetec Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.08% below the high.
Loading market information…
TWO · 1784.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
BIONET Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BIONET Corp.’s forward annual dividend is NT$0.88 per share, paid annual. The forward yield is 1.77% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
BIONET Corp.’s next earnings report is currently expected on Nov 17, 2026, with estimated earnings per share of NT$0.51. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow BIONET Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a global leader in umbilical cord blood preservation, serving clients across Taiwan and internationally. The company provides a comprehensive suite of stem cell banking services, encompassing the storage of general stem cells, mesenchymal stem cells, dental stem cells, adipose stem cells, and peripheral blood stem cells combined with immune cells. Beyond its core stem cell preservation, BIONET also conducts genetic testing services. Its product offerings further extend to anti-aging solutions leveraging stem cell technology, alongside its unique ANIKINE series. Additionally, the company is a pioneer in offering Exosome, an innovative cell-free therapeutic approach.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | Dec 31, 2024 | NT$0.66+46.14% vs estimate | NT$328.86M+2.13% vs estimate |
|---|
| Q4 2024 | Sep 30, 2024 | NT$0.23-45.26% vs estimate | NT$303.91M-3.83% vs estimate |
|---|
| Q3 2024 | Jun 30, 2024 | NT$0.33-30.39% vs estimate | NT$292.81M-4.0% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$20.10-NT$0.30 (-1.47%)
Savior Lifetec Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.08% below the high.
NT$23.30-NT$0.20 (-0.85%)
Orient Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.28% below the high.
NT$127.00NT$0.00 (0.0%)
Hi-Clearance Inc.’s quoted price sits in the lower half of its reported 52-week range, 7.97% below the high.
NT$199.00-NT$0.50 (-0.25%)
Brighten Optix Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
NT$88.10-NT$0.40 (-0.45%)
Formosa Optical Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.05% below the high.
NT$53.20-NT$1.20 (-2.21%)
Ever Fortune.AI Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.26% below the high.
NT$50.00-NT$1.80 (-3.47%)
Panion & Bf Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.55% below the high.
NT$87.50-NT$3.40 (-3.74%)
Onyx Healthcare Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.17% below the high.
